Udvalget for Veterinærlægemidler (CVMP) konkluderede, at fordelene ved ProMeris opvejer risiciene ved behandling og forebyggelse af loppeangreb hos katte.
The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of ProMeris exceed the risks for the treatment and prevention of flea infestations in cats.